You may have heard that a small minority of people have not been invited to screening appointments because of an error in how GP offices have registered them. This issue affects screening invitations for bowel cancer, breast cancer, cervical cancer, and …
You may have seen recent reports about the decision to not recommend a life-extending drug called Enhertu (Trastuzumab Deruxtecan) for the treatment of breast cancer on the NHS. Following ongoing commercial discussions between NICE, the NHS and the drug manufacturer, …
The process of cervical screening is to be changed to allow women to benefit from better, more accurate tests, Public Health Minister Jane Ellison announced.
An innovative scanning system is hoping to prevent NHS patients with head and neck cancer from having to undergo traumatic post-treatment surgery.
A new and potentially ground-breaking vaccine aimed at enabling the immune system to fight against advanced cancer is being trialled by scientists in London and Guildford, thanks to Government investment in the National Institute for Health Research (NIHR).
Recent Comments